Bryan Allinson Director Technology Transfer Office Ohio University Presentation to OU Foundation...
25
Bryan Allinson Director Technology Transfer Office Ohio University Presentation to OU Foundation Board of Directors’ TECHNOLOGY COMMERCIALIZATION COMMITTEE TECHNOLOGY COMMERCIALIZATION COMMITTEE Lynn Gellermann Director Center for Entrepreneurship Ohio University
-
Upload
alexia-stevens -
Category
Documents
-
view
221 -
download
0
Transcript of Bryan Allinson Director Technology Transfer Office Ohio University Presentation to OU Foundation...
Bryan AllinsonDirector Technology Transfer OfficeOhio University
Presentation to
OU Foundation Board of Directors’
TECHNOLOGY COMMERCIALIZATION COMMITTEE TECHNOLOGY COMMERCIALIZATION COMMITTEE
Lynn GellermannDirector Center for EntrepreneurshipOhio University
Vision StatementVision Statement
“The Ohio University Technology Transfer Office facilitates and accelerates the movement of technology out of the university and into the marketplace through a collaborative and problem solving approach, ‐providing validation, sustainability and improvements to society.”
2
“The Vice President for Research division promotes Ohio University's research mission to advance excellence in the search for new information, knowledge, understanding and creative endeavors.”
Societal Benefits of Ohio TechnologySocietal Benefits of Ohio Technology(Selected products from existing licenses)(Selected products from existing licenses)
4
Somavert®: Treating the cohort of 10,000 acromegaly (hyperthyroid) patients SEI: Better air quality, reduced toxin and carbon emissions
ABCDTM: Improved road conditions, verified for safety
FMW: Increased stability and support for military and commercial air travel
Thyretain®: Guiding therapy for thyroid conditions
E3: Clean fuel utilizing wastewater feed
Breadth and Selected AreasBreadth and Selected Areas
• Biomarkers and genetics
• Biorepository and blood disorders
• Cellular and molecular biology
• Healthcare delivery• Healthcare IT• Medical devices• New therapies• Osteopathic
medicine• Plant based
therapeutics• Thyroid conditions
6
World Health and Quality of Life
Resource Sustainability Society and Culture
• Algae fuel research• Battery research• Fuel cells• Corrosion inhibition• Green technology• Neutralize acidity• Renewable energy• Reduced emissions• Superconductors• Water treatment
• Air and ground transportation
• Communication Software
• Game design• Fine arts• Immersive video
intelligence• Logistics• Nanotechnology• Reduced power
consumption• Social media
IP Metrics and GoalsIP Metrics and Goals
7
58 / 57 / 44
Asset Metrics
• 63 issued patents• 159 patents pending• 16 disclosures in FY10
• 40% of IP licensed• 12 active licenses and options
+ Active startup with commercial license agreement with equity (< 10 yrs)
• 3 active+ startups (as of July 12, 2010)
License Metrics
Startup Metrics
41 / 9 / 13
Asset Goals
• Marketable inventions• Unmarketable or unpatentable inventions• Disclosures
• Licenses• Industry partner discussions
• Startups• Development funding• Pool of serial entrepreneurs (EIRs, networks)
License Goals
Startup Goals
6 / 4 / 6
UserOne
Licenses:Pfizer, SEI, FMW, Diathegen I, Diathegen II, GlycoRx (o), Faradox (Nanohmics), Interthyr, Interthyr (o), DHI, EZ Asphalt, Green Bios[E3 in final stages, but not yet complete]Startups (with equity and comm. license)EZ Asphalt, Diathegen, Green Bios[No equity with Interthyr, E3 nearly complete]
Res
ourc
es A
vaila
ble
>
Basic Translational Applied Tech Transfer / Pre-seed Seed Early Mid Late Research Research Research Commercialization
< Public SectorFunding
Available
Private Sector >FundingAvailable
Tot
al V
alue
The “Gap”The “Gap”
Resource constrained
Develop demonstrated concept (research to deployment)
Stakeholder execution/alliances(industry, entrepreneur, investor)
Protect IP assets (market exclusivity)
Engage market(business development)
Best Practices to Address Best Practices to Address The “Gap”The “Gap”
9
• Invest in Applied Research– Fund proof-of-concepts– Develop product and service models
• Invest in Technology Transfer– Execute research to deployment– Internal investment – Directed grant funding (e.g. Third Frontier)
• Invest in Entrepreneurs– Build talent pool for innovation based businesses – Entrepreneurs for high risk ventures
• Encourage Gov’t Policy for Pre-Seed capital– Tax incentives for angel investment as source of capital
TTO Organizational MatrixTTO Organizational MatrixVice President For Research
Rathindra Bose PhD
Technology Transfer OfficeBryan Allinson MBA, Director
Industry LicensingAssociate Director
Student Interns
Partners•Industry
•Federal and State Government Agencies
•Marketing Consultants
New Enterprise Creation+^
[EIRs*+, MBAs+]
Partners•Center for Entrepreneurship
•TechGROWTH•Entrepreneur Networks
•Angel Networks, Seed Funds, Venture Capital Firms and
Partners
IP Asset Management,Billing and Compliance
Research Asst. Student Interns
Partners•University Counsel
•Ohio Attorney General•Law Firms : Patent, Trademark
and Copyright •IP Asset Management
Partners
* Proposed in: *TechGROWTH proposal, + RFI, ^Strategic Plan
10
TTO Advisory ^
[TBD^]
weinberm
The partners in the boxes need to be in separate boxes with arrows to partners which are normally not part of a units organizational chart.
Center for Entrepreneurship (CE)Center for Entrepreneurship (CE)
• Partnership between College of Business and Voinovich School
• Build on and institutionalize existing programs and assets
• Support Vision Ohio goals and core values• Support OU Centers of Excellence• Promote entrepreneurial culture throughout
the University and region
11
CE GoalsCE Goals• Education
– Multidisciplinary certificate program– Academic curriculum, applied learning, mentoring and
continuing education – across all campuses• Regional Service Mission
– Hands-on business assistance for new and existing companies
• Entrepreneurial Support and Business Development– Network of internal and external human and investment
capital resources to help develop companies and commercialize technologies
12
CE Start-Up ActivitiesCE Start-Up Activities
• Piloted academic and applied courses• Successful Oasis Business Plan Competition• Student Entrepreneur Club formed• TechGROWTH Ohio: Supporting OU and regional
tech-based business development• Collaboration with TTO• Groundbreaking of Entrepreneurship & Technology
Center at OU – Chillicothe campus
13
Advisory services, executives-in-residence, grant support and seed-stage investment capital for technology firms
Over 2,000 applicants; 300 qualified clients; 150 active clients Grants of $2.6 million and investments of $1 million provided
to-date Leverage of State dollars is 7:1 Affiliate: East Central Ohio Tech Angel Fund (ECOTAF) Issue 1 approved by 62% of voters; Third Frontier program
renewed; more competitive funding coming available15
Entrepreneurial IP ActivityEntrepreneurial IP Activity
16
Innovator Firm or Lab Field TTO/TGO Funding License Status Success
Bergmeier Promiliad Medical - Pharma - Antibiotic/MRSA P 412,747 Bose Medical - Pharma - Cancer PChoi Medical - Device 49,924 Hallowell Medical - Device 26,769 Kieliszewski Plant genetics PKohn, Goetz Interthyr Medical - Pharma L 2,257,930 Kopchick DiAthagen Medical - Pharma L 60,000 Scarbrough** Medical - Pharma/Device - Obesity P
SUBTOTAL 2, 4 2,807,370 Bayless, Stewart Algae Reactor Alternative Energy P 50,000
Botte E3 Technologies Alternative Energy - wastewater/fuel L 2,103,892 Kraft Energy conversion 50,000 Pasic Advanced Materials
SUBTOTAL 1, 1 2,203,892
Berger** Rythmatics Interactive digital media *Bowditch IVIN Interactive digital media PKim EZ Asphalt Transportation - asphalt testing L 148,604 Liu VITAL Lab Interactive digital media PSchaaf** Imgur Interactive digital media *Thompson, Perkins** Pantheon Studios Interactive digital media *Liu Digital Financial Literary Interactive digital media 900,000
SUBTOTAL 1, 2 1,048,604
19 12 12 4, 7 6,059,866
Sources of metrics:Promiliad: Ph II STTRChoi, Hallowell, Botte, Kraft: TechGap AwardInterthyr: Ph II STTR Nat'l Inst HealthDiathagen: Athenian VenturesBayless: Federal grantBotte: Dept of Defense federal earmarkKim: Federal Highway Administr. grantLiu: Albany NY Credit Union Assoc and sales
Commercialization ApproachCommercialization Approach (Generic)
17
Faculty Communication Deployment StrategyNew Service Line v. New Startup
Invention Disclosures
Research Funding
Patenting Licensing
Market assessmentPatent assessment
When to Spin-out?When to Spin-out?Technology Commercialization (TTO)
En
tre
pre
ne
urs
hip
(C
E)
Ind
ust
ry S
po
nso
red
Re
sea
rch
(O
SP
)
Enterprise Creation
IndustryPartnering
18
Level of Market DisruptionPerceived cost to industry
Value ofIntellectual Property
Market barrier
Commercialization ApproachCommercialization Approach(Functional)
Patenting(20 year Barrier
to Entry)Launch new service line
License to industry
Alliance management
Identify industry partner
New service line v. New business
CE & support mobilization
License to startup
Launch new enterprise
19
Marketable Invention Identified
Disclosure
Review
Engagement /Business Plan
Center for Entrepreneurship
Assistance
Advisory Servicesand EIR’s
TTO Function
CE Function
Joint TTO / CE Function
Capital Access Approach
Strategic Direction / Board
Research
20
COMMITTEE MEMBERS
Shawn Osterman Associate Dean, College of Engineering & TechnologyHoward Dewald Associate Dean, College of Arts & SciencesJack Blazyk Associate Dean, College of Osteopathic MedicineEric Rothenbuhler Associate Dean, College of CommunicationsJen Horner Associate Dean, College of Health and Professional Services David Wight Director, Edison Biotechnology InstituteJennifer Simon Director, Innovation CenterKevin Aspegren Director, Applied Learning, Center for Entrepreneurship
* Proposed following RFI
Roles of BD Committee*Roles of BD Committee*
• Committee will – Communicate existing cross-university resources– Provide guidance on how to seek external resources– Communicate key metrics– Help address questions on current strategy and policy
• Committee will not– Make decisions on specific technologies– Make decisions on terms in contracts– Make financial decisions– Make strategy or policy decisions
21
* Proposed following RFI
Example Company ProfilesExample Company Profiles• E3 Technologies
– Pioneering new OU Commercialization Processes– Electrolysis technology for energy conversion
• Promiliad– TGO early-stage funding for proof of concept validation– New antibiotics for drug-resistant bacteria
• IVIN 3D– First OU Licensing “option” to test startup viability– Building interior simulations in virtual gaming environment
• Pantheon Studios– First student spinout from OU’s Interactive Digital Media program– An interactive game-development and virtual animation company
22
23
Projections: Projections: 2010 – 20112010 – 2011
Pre-seed investments in 2-4 OU tech companies
Grants to 5-8 OU tech companiesContinue generating external financial
leverageSeek 2-4 “angel” investmentsSeek first institutional venture capital
placement
23
24
Projections: Projections: 2010 – 20112010 – 2011
CE assist TTO with market assessmentsExpand venture and business advisory
networksIncrease invention disclosuresIncrease licensesApply for new rounds of funding from Third
Frontier program – need matching $$$More human and investment capital
24
Thank you!Thank you!Bryan Allinson, DirectorTechnology Transfer Office
740-593-0976
[email protected]/research/tto
Lynn Gellermann, DirectorCenter for Entrepreneurship
Executive DirectorTechGROWTH Ohio
740-597-1722
[email protected]@techgrowthohio.com
www.techgrowthohio.com
25
